Connection
Michelle Barron to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Michelle Barron has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
|
|
Connection Strength |
|
 |
|
 |
|
0.080 |
|
|
|
-
Golightly LK, Barber GR, Barron MA, Page RL. Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liability. Drug Metabol Drug Interact. 2013; 28(1):49-58.
Score: 0.080